To Browse a Full Report with TOC: http://www.researchmoz.us/pharmapoint-meningococcal-vaccines-france-drug-forecast-and-market-analysis-to-2022-report.html
GlobalData expects growth in the meningococcal vaccines market to be primarily driven by the launch of serotype B vaccines, which address a critical unmet need in the treatment landscape. Vaccines that better protect infants and/or provide a longer duration of immunity also have an opportunity to seize market share during 2012-2022.
GlobalData does not expect relative patient share to change within the MenC conjugate space because Nuron Biotech’s Meningitec, Novartis’ Menjugate kit, and Baxter’s NeisVac-C all possess similar clinical profiles and price points. The MenC conjugate patient share is largely determined by prescriber preference in France and therefore is not expected to change drastically during the forecast period. The French government has expressed disappointment with the low coverage rates of its MenC immunization program and is expected to renew efforts to expand vaccine use (Stahl et al., 2013). In general, the sales potential in France is derived from the immunization recommendations, which largely determine vaccine usage.
To Download Sample Report With TOC: http://www.researchmoz.us/enquiry.php?type=sample&repid=170312
Scope
Overview of Meningococcal Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in France including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in France from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting France Meningococcal Vaccines market.
Reasons to buy
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of the competition by understanding the changing competitive landscape for Meningococcal Vaccines
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of drug performance
Obtain sales forecast for drugs from 2012-2022 in France
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
3 Disease Overview 12
3.1 Etiology and Pathophysiology 13
3.1.1 Etiology 13
3.1.2 Pathophysiology 15
3.2 Symptoms 17
3.3 Prognosis 18
4 Disease Management 19
4.1 Meningococcal Immunization Policy 20
4.2 France 22
4.2.1 Meningococcal Immunization Recommendations and Policies 22
4.2.2 Clinical Practice 24
To Download Sample Report With TOC: http://www.researchmoz.us/enquiry.php?type=sample&repid=170312
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
No comments:
Post a Comment